Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.
J Hematol Oncol. 2019 Oct 29;12(1):111. doi: 10.1186/s13045-019-0798-2.
J Hematol Oncol. 2019.
PMID: 31665051
Free PMC article.
Review.